Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
BMC Neurosci
    December 2023
  1. KOLONICS A, Bori Z, Torma F, Abraham D, et al
    Exercise combined with postbiotics treatment results in synergistic improvement of mitochondrial function in the brain of male transgenic mice for Alzheimer's disease.
    BMC Neurosci. 2023;24:68.
    >> Share

    March 2023
  2. SHEKARIAN M, Salehi I, Raoufi S, Asadbegi M, et al
    Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer's disease.
    BMC Neurosci. 2023;24:20.
    >> Share

    February 2023
  3. MAITI P, Paladugu L, Dunbar GL
    Retraction Note: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
    BMC Neurosci. 2023;24:16.
    >> Share

  4. LIU Y, Meng Y, Zhou C, Yan J, et al
    Activation of the IL-17/TRAF6/NF-kappaB pathway is implicated in Abeta-induced neurotoxicity.
    BMC Neurosci. 2023;24:14.
    >> Share

    March 2022
  5. CUCOS CA, Dobre M, Dragnea EM, Manda G, et al
    Increased MYD88 blood transcript in a mouse model of Alzheimer's disease.
    BMC Neurosci. 2022;23:13.
    >> Share

  6. O'DAY DH, Huber RJ
    Calmodulin binding proteins and neuroinflammation in multiple neurodegenerative diseases.
    BMC Neurosci. 2022;23:10.
    >> Share

    January 2022
  7. TU H, Zhang ZW, Qiu L, Lin Y, et al
    Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
    BMC Neurosci. 2022;23:3.
    >> Share

    September 2021
  8. WEN J, Zhao M, Sun W, Cheng X, et al
    Publisher Correction to: Uptake of Abeta by OATPs might be a new pathophysiological mechanism of Alzheimer disease.
    BMC Neurosci. 2021;22:58.
    >> Share

  9. WEN J, Zhao M, Sun W, Cheng X, et al
    Uptake of Abeta by OATPs might be a new pathophysiological mechanism of Alzheimer disease.
    BMC Neurosci. 2021;22:53.
    >> Share

    August 2021
  10. KILE S, Au W, Parise C, Rose K, et al
    Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease.
    BMC Neurosci. 2021;22:49.
    >> Share

    June 2021
  11. LI P, Xu J, Gu H, Peng H, et al
    Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal-CA1 projection.
    BMC Neurosci. 2021;22:41.
    >> Share

    May 2021
  12. RINGLAND C, Schweig JE, Eisenbaum M, Paris D, et al
    MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
    BMC Neurosci. 2021;22:39.
    >> Share

    March 2021
  13. GUZMAN-RUIZ MA, Herrera-Gonzalez A, Jimenez A, Candelas-Juarez A, et al
    Protective effects of intracerebroventricular adiponectin against olfactory impairments in an amyloid beta1-42 rat model.
    BMC Neurosci. 2021;22:14.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016